Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study

Pharmacological treatments including antivirals (Lopinavir/Ritonavir), Immuno-modulatory and anti-inflammatory drugs including, Tocilizumab and Hydroxychloroquine (HCQ) has been widely investigated as a treatment for COVID-19. Despite the ongoing controversies, HCQ was recommended for managing mild...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Saudi pharmaceutical journal 2020-12, Vol.28 (12), p.1877-1882
Hauptverfasser:	Almazrou, Saja H., Almalki, Ziyad S., Alanazi, Abdullah S., Alqahtani, Abdulhadi M., Alghamd, Saleh M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Cohort study Coronavirus disease COVID-19 Hydroxychloroquine Life Sciences & Biomedicine Original Pharmacology & Pharmacy Saudi Arabia Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!